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ABSTRACT 
LOGAN H. RAMSEY: Patient perceptions of medication therapy management targeted 
for adherence following the provision of influenza immunizations by student 
pharmacists: Preliminary findings 
(Under the direction of Ashley W. Ellis) 
 
Objective: To examine patients’ opinions of clinical pharmacy services, especially 
Medication Therapy Management (MTM), following the administration of influenza 
immunization. 
Methods: The McLean Institute for Public Service and Community Engagement at the 
University of Mississippi funded a service-learning project for student pharmacists to 
administer influenza immunizations to medically underserved patients. The project was 
conducted at a clinic for uninsured patients in Southaven, Mississippi but was open to the 
public. Patients (n=52) received an influenza immunization followed by a personal 
medication record during the observation period. Students, under the supervision of a 
licensed pharmacist, then provided a medication review and Drug Adherence Work-Up 
(DRAW) to identify adherence problems. A survey was administered to patients 
regarding services received. Demographics and beliefs on pharmacists’ roles were also 
assessed. 
Results: 30% of the sample reported a household income below $15,000 and 33% lacked 
health insurance. However, most patients attempt to obtain a flu shot every year (M=4.22; 
Likert scale 1 to 5). 97% indicated trust in pharmacists’ abilities as clinical providers. 
63% of patients (n=33) reported taking 1 or more prescription medications daily, with a 
mean number of 3.6 medications. Medication adherence problems were identified in 
approximately half (49%) of patients. Respondents noted “forgetting” as the primary 
relevant issue. Two-thirds of patients (65%) were not aware of pharmacist-provided 
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MTM. Overall, 80% of patients found the combined immunization and MTM a beneficial 
service (M=4.38; Likert scale 1 to 5). 74% would visit a community pharmacy to receive 
further MTM services in the future. 
Conclusions: While survey results indicate low awareness of MTM, a significant number 
of patients experienced medication adherence issues. Pharmacy visits for annual 
influenza immunizations may provide an excellent opportunity for pharmacists to 
implement the model in this study and provide MTM or adherence services. 
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CHAPTER I 
 
Introduction 
  
History of Vaccination 
 As civilizations developed, the human race made the shift towards centralized 
agrarian societies, and pathogens evolved to spread illness from one human to the next.1 
Living in close proximity and sharing water supplies within cities increased the severity 
of infectious viruses and bacteria to “epidemic” levels.1 One such epidemic included the 
debilitating and highly lethal Variola major virus, more commonly known as smallpox. 
At one point, fatality rates for smallpox rose to 60% in adult victims and 80% within 
infected infants.2 By the 18th century, smallpox related illness caused 400,000 deaths in 
Europe every year.2  
 Fortunately, Edward Jenner – an English physician and scientist – conceived an 
idea to cure this infectious disease in 1796.2 Jenner chose to deliberately infect a patient 
with the cowpox virus.2 After experiencing a mild form of cowpox illness, the patient 
recovered within the span of a week. A few months later, Jenner exposed the patient to 
the live, active smallpox virus. As Jenner hypothesized, the young male showed 
resistance to the virus and did not develop any symptoms of the smallpox disease.2 Thus, 
the preventative health service of immunization was invented. 
 Approximately two centuries after Jenner’s investigation, all known cases of the 
smallpox disease were eliminated in 1977 through the implementation of universal 
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vaccination.3 Despite eradication of smallpox, however, the battle against infectious 
diseases is far from won. In particular, the influenza virus causes serious illness and even 
death every year. The Centers for Disease Control and Prevention notes that annual 
influenza vaccinations are especially important for protecting those at risk for 
complications, such as elderly patients, young children, and pregnant women.4 Based on 
data from 2012-2013, seasonal flu vaccination coverage in the United States averaged 
56% for children and 42% for adults with 73,130 collected specimens positive for 
infection with influenza virus.5-6 
 
History of American Pharmacy 
 While medical advancements such as vaccinations moved forward, the profession 
of pharmacy developed concurrently. By the early 1700s in New England, a substantial 
amount of “apothecary shops” started up in communities and provided numerous plant-
based medications to patients.7-8 In the year 1752, Jonathan Roberts became the first 
dedicated apothecary at the nation’s earliest hospital in Pennsylvania.7 The expanding 
responsibilities of the apothecary set the precedent for two primary roles in modern day 
pharmaceutical care: community pharmacy and institutional pharmacy. 
 Following the conclusion of the Revolutionary War, apothecaries and druggists 
started working with numerous chemicals for their medicines including sulfuric acid, a 
chemical still commonly used for pharmaceutical purposes today.7 In 1821, the 
foundation of the Philadelphia College of Pharmacy provided the first professional school 
of instruction for pharmacists.7-8 The profession of pharmacy became more distinct and 
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separate from medicine with the establishment of the American Pharmaceutical 
Association (APhA) in 1852.7  
 The University of Mississippi, recognizing the need for pharmacy education, 
established the state’s first and only School of Pharmacy on September 24, 1908.9 The 
initial School of Pharmacy consisted of seven faculty members and only 15 students.9 
After 108 years of growth, the School of Pharmacy currently includes 114 faculty 
members and over 350 professional students striving to advance the profession of 
pharmacy. 
 
Modern Roles of the Pharmacist 
 As modern health care providers, pharmacists are critical for maintaining public 
health and wellness. Combining medical and professional skills with the knowledge of 
immunization procedures, pharmacists can act as powerful advocates for preventative 
health care measures such as immunizations. As part of the continued endeavor to 
increase influenza vaccination rates, community pharmacists who receive the appropriate 
training are uniquely placed to intervene and provide clinical immunization services.10  
 Below average access to primary care remains a significant barrier for 
underserved patients especially in rural locations. According to the Mississippi State 
Department of Health, 75 out of 82 counties in Mississippi are currently designated as 
Health Professional Shortage Areas (HPSA).11 Pharmacists are in a position to fill the 
primary care gap with clinical services such as immunizations and Medication Therapy 
Management (MTM). Medication Therapy Management includes clinical services such 
as disease state management, Medication Therapy Reviews, and medication plans 
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focusing on adherence and safety.12 Pharmacists are among the most accessible members 
of the health care team. According to The National Association of Chain Drug Stores, the 
majority of Americans (93%) live within 5 miles of a community pharmacy, and the 
average distance to a retail pharmacy is only 1.26 miles.13 Patients are able to visit retail 
pharmacies without an appointment and receive counseling for their medication related 
problems. Patients can also seek readily available immunization services in all 50 states.14  
 More than 150,000 pharmacists have undergone training to administer many 
immunizations including the annually recommended influenza shot.14 As stated by the 
Centers for Disease Control (CDC), between 5 and 20 percent of the United States 
population becomes infected with the influenza virus annually.14 Throughout the past 3 
decades, influenza related deaths have ranged from 3,000 to 49,000 each year.14 Patients 
who decide to receive the influenza vaccine can benefit financially through decreased 
visits to the doctor and less time off work. More importantly, immunizations can prevent 
unnecessary death caused by the influenza virus and associated secondary illness such as 
pneumonia. 
 In addition, best practices indicate “vaccine providers…should consider observing 
patients (with patients seated or lying down) for 15 minutes after vaccination to decrease 
the risk for injury.”15 Pharmacists can use the suggested 15 minute waiting period after 
providing an influenza vaccine to engage the patient in further clinical services, such as 
Medication Therapy Management including a Personal Medication Record (PMR).16 
While MTM is generally provided during a scheduled appointment, MTM services may 
be provided for walk-in patients, similarly to the provision of influenza immunizations.16 
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The overall focus in MTM shifts from simply dispensing the prescription to providing 
patient-based care through clinical pharmacy services.16  
 Another important aspect of MTM includes the chance to assess and improve 
patients’ medication adherence. According to the Network for Excellence in Health 
Innovation, as many as 2 billion occurrences of medication non-adherence are 
preventable annually.17 As a result, $290 billion in health care costs is wasted every year 
due to medication non-adherence.17 While medications have the potential to effectively 
treat a multitude of problems, approximately 50% of patients do not correctly take their 
medications.17 Though taking a prescription medication might appear simple enough, 
Brown and Bussell explored the nature of medication adherence and found the issues 
“extremely complex.”18  
 Brown and Bussell also point out that treating medication adherence requires an 
individualized approach because each patient has different issues and behaviors.18 
Assessment of adherence comes from two primary sources. Subjective information may 
be uncovered by directly questioning the patient, patient’s family, and physicians.18 
Objective information is obtained from counting pills, checking the number of pharmacy 
refills, and using electronic medication monitoring systems.18 Pharmacists have the 
ability to directly monitor medications dispensed while also providing individualized 
adherence management through engaging the patient in MTM services. 
 
Mississippi Delta and Health Disparities 
 The lack of proper medication adherence results in decreased overall health 
outcomes and increased patient mortality.18 Potential causes that lead to lower levels of 
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adherence include several patient based factors. Significant reasons underlying non-
adherence include “lack of understanding their disease, lack of involvement in the 
decision making process, and suboptimal medical literacy.”18 Approximately 90 million 
people in the United States have medical literacy that is deemed inadequate.19 Examples 
of low health literacy include inability to interpret a prescription drug bottle label, not 
understanding medical education brochures, confusion regarding doctor's directions and 
consent forms, and difficulty negotiating complex health care decisions.20  
 The correlation between low medical literacy and health disparities continues to 
be explored, especially in areas of economic poverty. Zoellner et al. reported that 64% of 
residents in the Mississippi Delta function at the lowest tiers of literary capability.21 The 
population within the Mississippi Delta consists of a higher than average percentage of 
African Americans and increased prevalence of chronic diseases such as diabetes and 
cardiovascular disease.21 Zoellner et al. conclude, “Mississippi is one of the most health 
disparate regions in the United States.”21  
  According to Cossman, only 12% of the primary care physicians working in 
Mississippi are practicing in the Delta, although almost 20% of the state’s population 
resides in this region.22 The lack of providers in the Delta creates even more barriers to 
access for primary care services. As health care professionals search for new methods to 
combat the health disparities present in Mississippi, pharmacists are available as highly 
accessible and trusted sources of health management.  
 The roles required of pharmacists have changed greatly over time, from 
apothecary dispensing functions to modern clinical provider. As the practice of pharmacy 
continues to change within the health care system, utmost importance remains centered 
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on the oath that every pharmacist takes to “apply knowledge, experience, and skills to the 
best of my ability to assure optimal outcomes for my patients.” Pharmacists have the 
ability to step in and fill the primary care gap present in underserved areas. This study is 
important in the field of pharmacy practice because it seeks information on ways 
pharmacists can impact and improve the lives of patients they serve. In particular, this 
study investigates the possibility of using clinical services, such as immunizations, to 
further engage with patients and uncover more serious medication issues, including non-
adherence. 
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CHAPTER II 
Literature Review 
 Previous research studies have considered both pharmacist-provided 
immunizations and medication therapy management. Numerous studies have inquired 
about patient perceptions on clinical pharmacy services including MTM.23-27 However, 
studies have rarely focused on MTM targeted towards underserved areas such as the 
Mississippi Delta. Few to none have considered patient opinions regarding conjointly 
provided MTM and immunization services.  
 
Pharmacist Provision of Influenza Immunizations 
 Pharmacists initially began the administration of immunizations as part of 
standard community practice in 1994.28 By 2002, less than a decade later, the American 
College of Physicians and American Society of Internal Medicine announced official 
endorsement of pharmacist-provided immunizations.29 In a 2012 publication, Murphy et 
al. evaluated the amount of pharmacist-provided immunizations at Walgreen’s 
community pharmacies in medically underserved areas (MUAs).29 Based on their 
findings, 43% of the United States population (132 million people) lives in areas 
designated as “medically underserved” with below average access to primary care 
services.29 The highest amount of MUAs (78%) was found within the state of 
Mississippi.29 
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 The current state of health care in the United States, specifically within 
Mississippi, requires serious attention. When almost 80% of the state does not have 
adequate access to primary care, the costs associated with treating chronic diseases such 
as diabetes and cardiovascular disease (CVD) will inevitably rise. The lack of access to 
preventive health services such as immunizations creates further problems. When too few 
people receive the influenza immunization, herd immunity cannot be achieved. Herd 
immunity is defined as “the resistance of a group to attack by a disease because of the 
immunity of a large proportion of the members…so not everyone in a population needs to 
be immunized to eliminate disease.”30 Thus, fewer patients obtaining immunizations in 
Mississippi will result in more of the population contracting the influenza virus. 
 Through the use of community pharmacists as immunization providers, 
Walgreen’s pharmacies in the study by Murphy et al. supplied influenza vaccinations to 
33,951 patients in MUAs in Mississippi.29 Steyer et al. concur with the information 
obtained through the Walgreen’s study by determining pharmacists have the ability to 
substantially increase the amount of patients who can obtain and receive the influenza 
immunization each year.31 
 Though pharmacists can offer better availability and access to immunizations, the 
perception and willingness of patients to utilize this service must also be considered. 
Based on data from the Department of Health and Human Services, only 26% of children 
between the ages of 5 and 12 received the influenza vaccine in 2008.32 Pharmacists have 
the opportunity to educate parents about vaccination benefits for children and increase the 
rates of immunization among young age groups.  
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 A cross-sectional descriptive study conducted by Deshpande et al. questioned 
parents regarding pharmacist provision of the influenza vaccine to their children. This 
study further supported the accessibility of pharmacists as immunization providers: 98% 
of parents stated their child received the vaccination without making a prior 
appointment.10 Approximately 3 out of 4 parents indicated the desire to utilize a 
pharmacy again for their child’s influenza shot next year.10 The results from the study 
conducted by Deshpande et al. are consistent with similar studies, such as Grabenstein, 
Guess, and Hartzema’s finding that “respondents vaccinated by a community pharmacists 
were satisfied with the experience and would recommend it to others.”33 
 
Medication Therapy Management 
 After almost 20 years of routinely provided immunizations by pharmacists, many 
patients are prepared to accept pharmacists as an available and trusted source for 
vaccination services. However, newly developed clinical pharmacy services are also 
becoming prevalent in community pharmacy settings. In particular, medication therapy 
management as a pharmacy practice service model could enable pharmacists to provide 
more extensive care for patients. 
 Lemay notes that, with the busy atmosphere common for many pharmacies, MTM 
offers the pharmacist direct, undisturbed communication with their patient.34 For 
pharmacists wishing to implement MTM services in their practice, the American 
Pharmacists Association (APhA) and the National Association of Chain Drug Stores 
(NACDS) determined the five core elements needed in an MTM service model (Table 1). 
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Table 1: Core Elements of Medication Therapy Management 
1 Comprehensive Medication Review (CMR) 
2 Personal Medication Record (PMR) 
3 Medication-related Action Plan (MAP) 
4 Intervention and/or referral 
5 Documentation and follow-up 
 Source: Lemay, Ginger. “Medication Therapy Management in Community Pharmacy Practice.” 
 Medicine and health, Rhode Island 95.9 01 Sep 2012: 281. Rhode Island Medical Society, 2013. 
  
 CMR appears as the first and most prominent feature of MTM. When performing 
a CMR, the pharmacist should review the patient’s current medications, both prescription 
and over-the counter, with the goal of improving the drug therapy outcome.16,34 The 
pharmacist then begins the PMR including information such as the patient’s name, date 
of birth, emergency contact, primary physician, allergies, and current medications the 
patient is taking.16 After looking for potential drug therapy problems (DTPs), the next 
step for the pharmacist includes suggesting solutions to any problems uncovered via the 
MAP.34 The patient may then utilize the MAP in future visits with his or her physician. 
Both PMR and MAP should be updated as often as possible to reflect changes in the 
patient’s drug therapy.34 
 Upon completing the first 3 steps, the pharmacist may choose an intervention by 
communicating directly with the patient about DTPs and adherence or by contacting 
fellow health care providers such as the patient’s physician.16 In some instances, the 
pharmacist might refer a patient to a particular health professional. For example, the 
pharmacist could send a patient with type II diabetes mellitus to meet with a dietician. 
Finally, a pharmacist should thoroughly document the patient care services completed 
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during the MTM session. Proper documentation allows the patient’s physician to 
understand the pharmacist’s recommendations, upholds professional accountability for 
the pharmacist, and further supports the value placed on pharmacist-provided MTM.16 
 Previous investigations have sought patient preferences regarding MTM services 
provided to Medicare Part D beneficiaries. According to data gathered by Hong et al., 
Medicare beneficiaries in Memphis, TN cited the associated cost with MTM as their 
greatest consideration.23 Another primary concern was choosing the optimal practice 
setting for MTM services. Participants in the study valued MTM services provided by 
pharmacists in face-to-face encounters over alternative settings such as via telephone or 
at their home.23 Participants reacted most favorably to MTM sessions lasting 
approximately 15 minutes.23 This indication in patient preferences suggests that 
pharmacists can use the short time period after immunizations, around 15 minutes, to 
offer medication therapy management to patients visiting a community pharmacy. 
 Lauffenburger et al. conducted qualitative investigations to uncover themes in 
patient preferences and opinions on MTM. When considering experiences receiving 
MTM, the primarily older adult participants recited the following benefits of MTM: 
comprehensive personalized care, medication review to increase effectiveness of 
medications, and interceding with health plans.25 As previously reported Hong et al., 
participants in the study by Lauffenburger also cited cost of MTM as the most prominent 
barrier to receiving the service.25 In rural, medically underserved areas like Mississippi, 
pharmacists must be especially sensitive to how the cost of MTM might affect the 
patient’s willingness to obtain clinical pharmacy services. An important goal for 
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improving MTM accessibility should include finding ways to make MTM an affordable 
service while maintaining financial viability for the pharmacist. 
 
MTM and Health Disparities 
 MTM shows promise for increasing patient adherence levels, but MTM also 
allows the pharmacist opportunity to improve disease state management for chronic 
illnesses like diabetes. Only a few studies have examined the effect of MTM on 
underserved and minority patients. Congdon et al. evaluated the effect of MTM on 
diabetic, underserved Hispanic patients by checking their glycated hemoglobin levels, 
commonly known as A1C.35 For patients with A1C values below 9%, there was small 
change in hemoglobin levels post-MTM services.35 However, for patients with A1C 
above 9%, the majority of patients (94%) show significant decrease in A1C levels 
averaging from 10.9% down to 8.8%.35 
 While a single MTM visit did not produce significant changes in A1C levels, 
patients who return to obtain multiple MTM visits also showed a significant decline in 
A1C.35 The trend suggested a correlation between increased MTM visits and better 
disease management of diabetes.35 When providing immunization services, pharmacists 
can use the opportunity to initiate an MTM encounter. However, scheduling follow-up 
MTM services appears important for substantial impact on diabetes management. 
 Taylor, Byrd, and Krueger also studied the effect of pharmacy services on patients 
with hypertension, diabetes, dyslipidemia, and anticoagulation therapy. Taylor, Byrd, and 
Krueger also targeted underserved patients; however this study took place in rural 
Alabama. The intervention in this study included MTM-style medication reviews, disease 
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education, and patient training for inhalers, glucometers, and pill boxes.36 After 12 
months of intervention services, the patients displayed significantly improved control of 
hypertension, hemoglobin A1C, and LDL cholesterol levels.36 It is also worth noting that 
medication adherence scores in the intervention group increased by 15%.36 Clearly, 
clinical pharmacy practice services have the capability to dramatically improve health 
outcomes and management of disease states, even specifically in disadvantaged 
populations. 
 The topic of health disparities is especially important when considering the 
Mississippi Delta, which has double the national poverty rate and a 38% obesity rate.37 
The poverty and obesity are undoubtedly factors in the very high incidence of diabetes 
found in the Delta. Ross and Bloodworth conducted research at 13 community 
pharmacies in a total of nine Delta counties to study the impact of a patient-centered 
health care model (PCHC) on rural communities.37 Initially, the Delta Pharmacy Project 
study only included Medicaid beneficiaries between 18 and 64 but expanded to include 
all patients over the age of 18 years old.  The PCHC was strongly based on both 
specialized and general MTM services. Pharmacists engaged the patients with face-to-
face MTM services, including CMR, and followed the core elements set out by the 
APhA.37 In total, 468 patients joined the MTM program supported by the Delta Pharmacy 
Project over a period of 2 years.37 
 Specific to medication adherence, the Delta Pharmacy Project discovered non-
adherence issues in 58% of patients.37 The study also measured blood pressure, 
cholesterol levels, and A1C with significant decreases observed over time on these 
measures.37 From an economic standpoint, the MTM interventions reduced costs by 
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decreasing emergency room visits, hospitalizations, and physician appointments for 
patients.37 The Delta Pharmacy Project further validated the apparent health care 
problems and disparities present in the Mississippi Delta. While this is preliminary data, 
the research conducted by Ross and Bloodworth also confirmed the ability of pharmacists 
to positively influence health outcomes in rural Mississippi.37 The study did not, 
however, inquire about patient perceptions regarding the MTM services received at the 
community pharmacies. 
 The clinical and financial findings by Ross and Bloodworth concur with a 
previous experimental, longitudinal pre-post study on MTM outcomes known as The 
Asheville Project. This research project by Bunting and Cranor considered the following 
measurements of health status: blood pressure (systolic and diastolic) and cholesterol 
(LDL and total).38 For both of these measurements, the improvement in patient health 
status was statistically significant over the 5-year duration of the MTM study.38 The 
patient’s improved health status was reflected in a significantly decreased amount of 
cardiovascular (CV) events among the cohort.38 The definition of CV events included 
“myocardial infarctions (MIs), non-MI acute coronary syndromes (ACSs), strokes, 
transient ischemic attacks (TIAs), acute episodes of heart failure (HF), coronary artery 
bypass grafts (CABGs), percutaneous transluminal coronary angioplasty (PTCA), and 
peripheral vascular disease (PVD).”38 
 Once again, the potential for MTM clinical services to improve health status was 
demonstrated in this research. The improvements following clinical pharmacy service 
programs are measurable and significant. The effect of targeting such clinical pharmacy 
services towards underserved populations requires further research consideration. 
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MTM and Pharmaceutical Education 
 While clinical community pharmacists innovate and incorporate MTM into the 
practice settings, pharmacy educators must also consider how courses in pharmacy school 
affect students’ ability to practice MTM. Galal et al. implemented a Medicare Part D 
elective course for 33 second-year (PY2) pharmacy students at the Thomas J. Long 
School of Pharmacy and Health Sciences. The focus of the study was measuring student 
pharmacists’ confidence and ability to provide MTM and influenza immunizations.39 
88% of the students entering the class did not have previous experience with MTM 
provision, and 64% did not have experience in administering immunizations.39 After 
assisting 401 Medicare beneficiaries during 9 events, the student pharmacists’ show 
significant increases in confidence ratings for provision of both immunizations and 
MTM.39 Qualitative results from the students included that the course was “challenging 
but rewarding, eye-opening, and inspiring.” Students also found that applying knowledge 
from the course to patient care settings was a substantial benefit.39 
 Student pharmacists who gain confidence in providing MTM and immunizations 
are better equipped to integrate clinical pharmacy practice services upon graduation. 
Pharmacy faculty and educators can consider the importance of implementing such 
courses within professional pharmacy degree programs. 
 
Summary 
 After a thorough evaluation of the scientific literature relating to medication 
therapy management, pharmacist provision of immunizations, and the impact of MTM on 
health disparities, pharmacists are in a prime position to provide clinical services and 
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improve health outcomes for patients. The literature also strongly suggests that the 
benefits of MTM and immunizations are both tangible and significant. However, the 
sufficient literature does not exist that considers patient perceptions and beliefs on the 
value of these services when provided in rural locations. The goal of this thesis is to 
examine the participants’ thoughts and opinions, particular when located in a region of 
disadvantaged economic and health status. 
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Chapter III 
 
Research Methodology 
 
Research Design 
 The overall design of the study conducted for this thesis was exploratory and 
descriptive. In particular, the study sought to explore the patient perceptions of conjointly 
provided influenza immunizations and Medication Therapy Management targeted for 
adherence. Thus, it was determined that patients in the study should receive a clinical 
pharmacy intervention prior to the survey assessment. Second year (PY2) student 
pharmacists from the University of Mississippi School of Pharmacy provided the services 
as part of a service-learning grant from the McLean Institute for Public Service for 
Community Engagement. Funding from the McLean Institute allowed for provision of 
free influenza immunizations and associated supplies. Further financial support for the 
project came from the Sally McDonnell Barksdale Honors College.  
 The intervention began with a free influenza immunization at a clinic designated 
for uninsured patients in Desoto County, specifically located in Southaven, MS. Patients 
not taking any medications did not undergo MTM and simply completed a partial survey. 
However, for each patient taking prescription medications, the student pharmacists (under 
the supervision of a licensed pharmacist) engaged the patients in a medication review and 
provided a Personalized Medication Record (PMR) during the waiting period following 
immunization. Next, students administered the Drug Adherence Work-Up Tool (DRAW 
tool) provided by the Million Hearts® Initiative through the U.S. Department of Health 
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and Humans Services to identify any existing adherence issues for the patients. After the 
DRAW tool was completed, student pharmacists provided adherence-focused MTM 
services. Finally, patients completed a survey designed to assess perceptions regarding 
the services received during the event. Pharmacy faculty members and residents provided 
oversight and guidance during the event if students had any questions or problems 
providing the services. The project flow chart (Appendix B) provides a visual 
representation of the project.  
 The instrument used to measure patients’ opinions and perceptions was a paper-
based survey provided in person. The patients completed the survey, which was approved 
by the Institutional Review Board at the University of Mississippi. Research emphasis 
was placed on the following objectives: 
 1) Determine patient perceptions of the roles of pharmacists, including trust in 
 pharmacists as clinical providers. 
2) Determine patients’ awareness of MTM. 
3) Determine patients’ perceived benefit and satisfaction from the MTM services  
received during the intervention. 
 4) Compare patients’ non-adherence with MTM helpfulness. 
 5) Compare patients’ self-reported non-adherence with DRAW tool results. 
  
Survey Development 
 The survey used in this study was designed to assess patients’ perceptions after 
receiving the clinical pharmacy services from student pharmacists. Because of the 
difficulty associated with obtaining follow-up surveys, especially without incentives, the 
! 20!
survey was administered immediately at the time of the intervention. According to Nulty, 
paper-based surveys provided substantially higher response rates than other formats. In 
particular, paper-based surveys gather stronger response rates than surveys sent out 
online.40 
 The survey used in this project (Appendix A) contained 25 items total. Many 
questions utilized the dichotomous measure of “yes” or “no.” The initial portion of the 
survey included nine questions focused on medication use and perceptions of 
pharmacists’ roles, with one open-ended qualitative measure. The next section provided a 
description of Medication Therapy Management to clarify the topic for patients. The 
following nine questions inquired about the MTM intervention, including another open-
ended qualitative measure. Five of the MTM questions obtained Likert-type responses on 
a scale of 1 to 5 (strongly disagree to strongly agree). Two questions were related to flu 
immunizations. Finally, the survey included a section of five questions on demographic 
information. 
 The survey included measures adapted from a survey administered by Law, 
Okamoto, and Brock.24 Permission to use and modify the questions was obtained by 
contacting the principal investigator, Anandi V. Law, BPharm, PhD. Several faculty 
members and one resident at the University of Mississippi School of Pharmacy also 
reviewed the survey, providing further validation.  
 Questions regarding demographics were placed at the end of the survey for two 
purposes: first, because patients were screened based on prescription medication use 
rather than demographic information, and secondly to procure responses to the more 
important questions on adherence and MTM before patients became weary with the 
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survey. The survey endeavored to maintain an appropriate logical flow by beginning with 
questions on medication use and pharmacists’ roles before moving to questions about the 
MTM services. 
 
Drug Adherence Work-Up Tool 
 For the purposes of assessing adherence, a cohesive and streamlined tool is 
essential for use in a community pharmacy practice setting. Doucette et al. developed the 
Drug Adherence Work-up Tool (DRAW) for use during pharmacist-provided MTM, 
specifically targeted for adherence.40 After implementing the tool, pharmacists in the 
study affirmed that using DRAW enabled better identification and resolution of 
medication adherence issues.40 DRAW considers the following factors affecting 
medication adherence: too many drugs or doses, forgetfulness, concern about medication, 
belief in medication effectiveness, medication costs and adverse effects.40 When 
attempting to provide MTM during an immunization visit, pharmacists can utilize 
DRAW as a streamlined method, especially in situations where adherence problems are 
suspected. 
 
Data Collection 
 The sample used in this study was collected during October and November of 
2013 at Desoto Health and Wellness Center in Southaven, MS. This location was deemed 
appropriate because of the underserved population targeted. According to the U.S. 
Department of Health and Humans Services, Southaven is designated as a medically 
underserved area of the state. While the clinic serves uninsured patients, the service event 
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was open and advertised to the public. With funding from the Sally McDonnell Barksdale 
Honors College, radio advertisements (Appendix C) went out on the air during the week 
prior to the event. The radio stations included IDIA-AM, WDIA-AM, and WEBL-FM. 
The purpose of radio advertising was to recruit a higher number of participants. Based on 
the RAOSOFT Sample Size Calculator, for a margin of error set at 10% and a 90% 
confidence level, the recommended sample size is 68. The McLean grant provided a total 
of 90 influenza immunization shots. The minimal risks to patients included soreness, 
redness, swelling, low-grade fever, and aches, as stated by the Centers for Disease 
Control and Prevention. 
 The primary selection criteria applied to patients was the use of prescription 
medications. Those who did not take prescription medications were not eligible to 
participate in MTM services. Before offering the survey to patients, student pharmacists 
followed a script (Appendix D) inquiring about willingness to participate in the study and 
required a minimum age of 18 years old. Following the survey, patients placed completed 
surveys in a confidential envelope.  
 
Data Analysis 
 Following the final collection of surveys, data was coded numerically and directly 
entered in Microsoft Excel. For example, “yes” responses designated as the number 1, 
and “no” responses designated as the number 2. While all surveys collected did not 
include personal identifiable information, each survey and DRAW tool was labeled with 
a unique number. This facilitated the correct matching between surveys and DRAW tool 
results. Data was imported into IBM SPSS Statistics for Macintosh, Version 21. Only 
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questions from patients taking prescription medications were used for analysis of 
questions regarding MTM services.  
 The survey provided descriptive and qualitative information about patients’ 
opinions to assess Objectives 1, 2, and 3. The Likert-type questions offered descriptive 
ordinal data for ranking patients’ agreement or disagreement on a scale from 1 to 5 
(strongly disagree to strongly agree. According to Sullivan and Artino, “the differences 
between ‘always,’ ‘often,’ and ‘sometimes’ on a frequency response Likert scale are not 
necessarily equal. In other words, one cannot assume that the difference between 
responses is equidistant even though the numbers assigned to those responses are.”42 
Thus, the use of parametric tests (t-tests, analysis of variance, Pearson correlations, 
regression, etc.) was avoided in the analysis of Likert-type responses. Descriptive 
statistics such as means, medians, standard deviations, frequencies, and percentages was 
deemed more appropriate for analysis of Likert data. 
 For Objective 4, the data on self reported non-adherence and MTM helpfulness 
was analyzed with a Fisher’s Exact test with 2x2 contingency table. For Objective 5, 
dichotomous survey questions were grouped by DRAW tool response and self reported 
non-adherence for paired nominal data analysis with McNemar’s test. A α-priori of 0.05 
was chosen to indicate statistical significance.  
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Chapter IV 
 
Results 
 
Description of the Sample 
 In total, 53 patients received a free influenza immunization and the associated 
MTM services, if applicable. All patients participated in the survey. However, one survey 
was omitted from the analysis due to insufficient completeness. Thus, the effective 
response rate for the survey was 98% (52 of 53).  
 Table 2 contains a description of the sample based on characteristics obtained 
through the demographic questions from the survey. 85% of patients in the study were 45 
years of age or older. Considering gender and ethnicity, the majority was female and 
Caucasian. Over one-third of patients (36.7%) reported a total household income below 
$25,000. 39.4% also reported having no form of health insurance.    
 Table 3 contains descriptions of medication use as reported by patients. The 
patients reported taking an average of 3.6 prescription medications per day. While 60.6% 
of patients claimed to have a method of remembering medications, approximately half 
(48.9%) experienced forgetfulness and non-adherence when taking their prescriptions. 
Furthermore, 70% visit a pharmacy with a frequency of at least once per month. 
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 Table 2: Demographic Characteristics  
Age (%) 
18 – 24 
 
3 
25 – 34 0 
35 – 44 12.1 
45 – 65 63.6 
65+ 21.2 
Gender  
Male 30.3 
Female 69.7 
Ethnicity  
Caucasian 93.9 
African American 6.1 
Hispanic 0 
Asian 0 
Other 0 
Total Household Income  
< $15,000 26.7 
$15,000 - $24,999 10 
$25,000 - $34,999 13.3 
$35,000 - $49,999 16.7 
$50,000 - $74,999 20 
> $75,000 13.3 
Health Insurance  
Medicare 6.1 
Medicaid 0 
Private provider 30.3 
Medicare + Private 12.1 
No insurance 39.4 
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Table 3: Characteristics of prescription medication use 
 
Mean number of prescription 
medications per day 
 
3.6 
Method of remembering medications 
 
(%) 
Yes 60.6 
No 39.4 
Forget to take medications  
Yes 48.5 
No 51.5 
Frequency of pharmacy visits  
Once a month 53.3 
More than once a month 16.7 
Less than once a month 26.7 
Unsure 3.3 
 
Objective 1: Determine patients’ perceptions of the roles of pharmacists, including trust 
in pharmacists as clinical providers  
 The majority of respondents indicated they would visit a physician when 
experiencing medication problems, as shown in Table 4. However, 36.3% indicated they 
would visit a pharmacist either alone or in conjunction with other health care providers 
for resolution of medication issues. Interestingly, over 20% of patients would visit 
multiple health care providers for help with medication problems.  
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Table 4: Who would you visit if you had a problem with 
your medications? 
 
Doctor 
 
51.5% 
Pharmacist 21.2% 
Nurse 3% 
Nurse practitioner 3% 
More than 1 of the above 21.2% 
 
 A clear majority believed pharmacists have the ability to manage and resolve 
medication related problems (Table 5). While patients preferred to visit a physician for 
medication problems, the belief in pharmacists’ capability to handle and resolve 
medication issues suggests patients would be open to receiving increased help from 
pharmacists. 
 
Table 5: Do you believe that pharmacists can help manage 
and fix problems with your medications? 
 
Yes 
 
90.6% 
No 9.4% 
 
 For the question on trust in pharmacists shown in Table 6, responses were 
analyzed from all patients who answered the question (n=50) because trust in pharmacists 
includes more factors than only prescription medication use.  Every patient in the study 
indicated trust in pharmacists, which is consistent with prior Gallup polls placing 
pharmacists among the most highly trusted professions.43 A follow-up question inquired 
about trust in pharmacists pertaining to the Medication Therapy Review. 
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Table 6: In general, do you trust pharmacists?  
 
Yes 
 
100% 
No 0% 
 
 A strong majority trusted pharmacists as providers of MTR services (Table 7). In 
this case, those who answered the question (n=32) already received MTM services during 
the intervention. Because patients experienced first hand the provision of a Medication 
Therapy Review, the beliefs presented indicate trust in pharmacists as clinical providers 
of medication management services. Thus, based on the descriptive responses in this 
section, patients did trust pharmacists both overall and for provision of clinical services. 
Finally, qualitative themes were gathered from an open-ended question on expectations 
regarding pharmacists. The most reported expectation of pharmacist included the 
traditional roles of dispensing and counseling (Table 8). 
 
Table 7: Do you trust pharmacists to provide a Medication 
Therapy Review?  
 
Yes 
 
96.9% 
No 3.1% 
 
Table 8: When you visit a pharmacy, what do you expect the pharmacist to do? 
Fill prescriptions Most frequent theme (n=14) 
Counsel and provide knowledge on side effects Second (n=9) 
Answer medication related questions Third (n=8) 
Prevent medication interactions / Friendy Least frequent (n=2) 
Project friendly attitude Least frequent (n=2) 
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Objective 2: Determine patients’ awareness of Medication Therapy Management   
 Survey results indicate low awareness of MTM. Two out of three patients (66.7%) 
did not know about Medication Therapy Management prior to the service event. 
However, approximately half of the sample (48.5%) reported non-adherence as a 
medication issue. While many patients could benefit from MTM, particularly for 
adherence, the majority simply was not aware this clinical pharmacy service existed 
(Table 9). 
 
 
Table 9: Have you heard of the term Medication Therapy 
Management before today?  
 
Yes 
 
33.3% 
No 66.7% 
 
Objective 3: Determine patients’ perceived benefit and satisfaction from the MTM 
services received during the intervention.  
 Three out of four patients (75%) perceived benefit after going through the MTM 
services provided at the intervention, as shown in Table 10. The positive feedback from 
patients suggests satisfaction with MTM even though most patients came into the study 
without prior awareness of these services. Though only 42% reported finding new ways 
to remember medication and increase adherence as a result of the service (Table 11), 
most patients (60.6%) indicated already having methods to remember medications before 
participating in the event. Further analysis between reported non-adherence and MTM 
helpfulness was conducted for Objective 4. 
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Table 10: Do you think you will benefit from the 
Medication Therapy Review?  
 
Yes 
 
75% 
No 25% 
 
 
Table 11: Did the Medication Therapy Review help you 
find new ways to remember to take your medicine?  
 
Yes 
 
42% 
No 58% 
 
 Responses for the Likert-type items shown in Table 12 included a range from 1 
(strongly disagree) to 5 (strongly agree). Overall, the Likert-type scores showed positive 
perceptions regarding the MTM services. The highest mean reflected perceived value in 
the Personal Medication Record given to each patient. About 64% of the sample reported 
increased understanding of accurate medication use as a result of the MTM intervention. 
Four out of five patients (80%) found benefit in the conjointly provided MTM and 
influenza immunization. Finally, 73% indicated willingness to visit their community 
pharmacy for further MTM services in the future. Finally, qualitative themes were 
gathered from an open-ended question on specific assistance provided by the MTM. The 
percentages of patients reporting the different themes are listed in Table 13. 
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Table 12: Likert-type responses rating satisfaction with MTM 
Question Mean Median Std. 
Deviation 
The Medication Therapy Review helped me 
understand how to properly use my prescription 
and over-the-counter medicines. 
 
3.97  4 1.06 
Getting my flu shot and Medication Therapy 
Review at the same time is a beneficial service. 
 
4.36  5 1.14 
I think the wallet card medication list provided 
by the pharmacist is a valuable tool. 
 
4.64 5 0.99 
I would visit my local community pharmacy to 
receive Medication Therapy Reviews in the 
future. 
 
4.12 5 1.26 
 
 Most patients reported the counseling and information on side effects during 
MTM as beneficial. However, over 20% specifically noted the pharmacist’s assistance 
with increasing medication adherence. Isolated themes included cost management, 
choosing appropriate medications, decreasing complications, smoking cessation, and 
assessment of blood sugar and blood pressure. 
 
Table 13: Can you please list some ways the Medication 
Therapy Review helped you?  
 
Counseling and knowledge of side effects 
 
44.4% 
Increase remembrance for taking 
medications 
22.2% 
Pharmacist knows what medications to 
prescribe 
5% 
Decrease medication complications 5% 
Ensure complete control of medications 5% 
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Provide assistance with medication cost 5% 
Smoking cessation services 5% 
Assess blood sugar, blood pressure, and 
family history 
5% 
  
  
Objective 4: Compare patients’ non-adherence with MTM helpfulness. 
 Table 14 contains the results of a Fishers Exact statistical significance test used to 
analyze 2x2 contingency tables. For this objective, the test compared the patients’ 
response to non-adherence based on forgetfulness (Question 3) and MTM helpfulness in 
remembering new medications (Question 14). 
 
Table 14: Forgetfulness vs. Helpfulness 
 MTM Helpful Total 
Yes No 
Forgetful 
Yes 
Count 11 4 15 
% within Forgetful 73.3% 26.7% 100.0% 
No 
Count 2 14 16 
% within Forgetful 12.5% 87.5% 100.0% 
Total 
Count 13 18 31 
% within Forgetful 41.9% 58.1% 100.0% 
 
 
 According to the Fisher’s Exact Test, there was a statistically significant 
difference between two groups (p < 0.01). Thus, those who reported “yes” to the question 
on forgetfulness were more likely to find the MTM service helpful (73.3% vs. 12.5%, 
respectively).  
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Objective 5: Compare patients’ non-adherence and DRAW tool efficacy. 
 Table 15 contains the results of McNemar’s Test and Cohen’s kappa coefficient 
as statistical measure of agreement between categorical items. For this objective, the test 
compared patients’ responses to non-adherence based on forgetfulness (Question 3) and 
the DRAW tool results (problem identified vs. no problem identified). 
 
Table 15: Forgetfulness vs. DRAW Tool 
 DRAW Total 
Yes No 
Forgetful 
Yes 
Count 10 6 16 
% of Total 30.3% 18.2% 48.5% 
No 
Count 6 11 17 
% of Total 18.2% 33.3% 51.5% 
Total 
Count 16 17 33 
% of Total 48.5% 51.5% 100.0% 
 
  Based on the Kappa value (0.27, p=0.12), there was not statistically significant 
agreement between the two approaches to detect potential problems with non-adherence. 
However, the results of the McNemar test (p > 0.99) suggest there is insufficient evidence 
to state that the proportion of patients rated as non-adherent is different between the 
DRAW tool and the forgetfulness question. A total of 30.3% of the responses indicated 
agreement between non-adherence and DRAW problem, and 33.3% indicated agreement 
in adherence and no DRAW problem. Thus, the overall level of agreement was 63.6%. 
Based on this analysis, no definitive statements can be made concerning the concordance 
or discordance of these two approaches.  
 
 
! 34!
 
 
 
 
 
 
Chapter V 
 
Discussion and Implications 
 
 The primary purpose of this research project was to evaluate the current 
perceptions on adherence targeted medication therapy management as part of the 
influenza immunization administration workflow as reported by patients at a clinic for the 
medically underserved in Southaven, Mississippi. No prior studies in Mississippi provide 
a review of conjointly provided influenza immunizations and Medication Therapy 
Management.  
 
Limitations 
 One limitation in this study was the small sample size. Despite radio recruitment 
and advertising at the free clinic, only 53 subjects participated in the event even though 
90 free influenza immunizations were available for the project. Of those 53 subjects, only 
a smaller portion (n=33) took prescription medications. Statistical analysis of the study 
was at risk for failing to recognize statistical significance (Type II error). Thus, due to the 
small sample size, the ability to generalize the results discovered in the research is 
limited. 
 Secondly, any potential generalizations must consider the low diversity in patient 
demographics. The strong majority of patients who received the clinical services fell into 
the Caucasian ethnic category and female gender category.  
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 Finally, the study did not ask the patients to distinguish between student 
pharmacists and registered pharmacists. It is unknown how the patients would distinguish 
perceptions between student pharmacists and pharmacy practitioners with greater levels 
of experience providing MTM services. Also, the variation in quality between the levels 
of service provided by different students was not taken into account. However, the 
student pharmacists used clearly defined MTM tools such as DRAW and completed 
MTM training prior to the intervention. Therefore, it is reasonable to believe the level of 
service provided by the student pharmacists was adequate or better. 
 
Discussion and Implications 
 The patients in the study indicated generally favorable perceptions regarding the 
clinical services they received, as indicated in Table 12. A clear majority trusted 
pharmacists as providers of clinical services. While most qualitative expectations of 
pharmacists centered on dispensing medications, respondents affirmed pharmacists’ 
ability to manage and resolve medication related problems. Based on the survey, most 
patients would return for further MTM visits in the future. Although limited by small 
sample size and its exploratory nature, the preliminary results of this study suggest that 
pharmacy practitioners in the Mississippi Delta and other rural locations might expect 
positive attitudes from patients engaged in clinical pharmacy services. The sustainability 
of MTM implementation is also supported by the patient’s willingness to seek additional 
MTM in the future. 
 While survey results indicate relatively low awareness of MTM, a significant 
number of patients experienced medication adherence issues. The DRAW tool was 
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heavily focused on maintaining or increasing adherence. It follows that patients 
experiencing difficulty with adherence are prime candidates for adherence-targeted MTM 
services, as used in this study. Indeed, from the results obtained through the survey, 
patients who reported non-adherence due to forgetfulness reported greater benefit the 
MTM intervention than patients who did not report any forgetfulness.  
 The findings of this study relate to the use of pharmacist administered influenza 
immunizations in that most patients taking prescription medications attempted to obtain 
an influenza immunization every year. Many patients also visited their community 
pharmacy once per month, if not more often. Community pharmacies that offer and 
advertise influenza immunizations might consider the interaction with patients during the 
flu shot as an optimal opportunity to provide MTM and adherence services.  
 Based on the findings of this study, the following recommendation for use within 
community pharmacy settings may be considered. During the brief waiting period 
following the immunization, a pharmacist could initiate dialogue with the patient by 
offering to discuss the patients’ medications. If the patient indicates willingness to talk 
about their medications, the pharmacist might ask: “Do you feel like you have too many 
medications or too many doses per day?” or “Do you sometimes forget to take your 
medication on routine days?” Based on the patient’s response to these questions, the 
pharmacist should consider using the DRAW Tool to further engage with the patient and 
provide recommendations such as adherence or memory aids, daily alarms, specialized 
packaging, medication calendars and medication synchronization. The pharmacist could 
also consider providing a Personal Medication Record, as many patients in this study 
found the PMR quite beneficial. Further, another benefit of using the DRAW tool in a 
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pharmacy practice setting where more than one pharmacist or student pharmacist 
provides immunizations is that all patients would receive consistent adherence 
interventions due to the structured nature of the conversation with the patient. 
 However, if the patient does not indicate any forgetfulness or problems managing 
doses, adherence-focused MTM is less likely to provide substantial benefits for the 
patient. Some patients indicated no forgetfulness, but the student pharmacists still 
uncovered adherence problems with DRAW tool. Forgetfulness is only one aspect of 
medication adherence problems. Other issues including medication side effects and cost 
may also affect adherence. The other causes for non-adherence might contribute to the 
lack of agreement found in Table 15. MTM services related to medication cost and side 
effects might provide additional benefits for these patients.  
 While influenza immunizations are a prime opportunity to engage patients, this is 
not the only occasion for pharmacists to offer clinical services. Pharmacists could also 
use routine pneumonia and shingles vaccines as a chance to offer MTM. Likewise, 
pharmacists also meet with patients for other services such as glucose monitoring and 
blood pressure check-ups. When providing clinical services, pharmacists have the 
opportunity raise awareness of MTM and potentially improve health outcomes by 
increasing medication adherence.  
 
Future Research Exploration 
 This research project only considered the perceptions reported by patients 
undergoing this intervention. However, it did not collect information on how students 
perceived these services. Further exploration may inquire about the impact of pharmacy 
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practice interventions on students providing the services. Another interesting and 
unexpected finding was that over 20% of patients reported seeking medication assistance 
from multiple health care providers. Research regarding perceptions of inter-professional 
management of medication, especially in rural environments use may be an additional 
avenue of investigation in the future.  
        In the only omitted survey, the subject was Hispanic and communicated primarily 
in Spanish. In future studies, having a survey already translated into Spanish could 
provide an alternate method for obtaining surveys from participants who are not fluent in 
English.  Also, this study did not evaluate patients’ willingness to pay for the services 
received. More research is likely necessary on the financial opinions of patients and 
potential compensation methods for pharmacists.  
 Finally, the intervention in this study combined the influenza immunization and 
MTM. Conducting future research with groups receiving only flu shots and only MTM 
versus the combined group would allow for in depth analysis of how patients in the 
Mississippi Delta distinguish between the benefits of these services. 
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APPENDIX A: SURVEY INSTRUMENT 
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APPENDIX B: INTERVENTION FLOW CHART 
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APPENDIX C: RADIO RECRUITMENT 
 
 
 !You!are!invited!to!a!community!health!fair!at!Desoto!Health!and!Wellness!in!Southaven!on!Saturday!November!2!from!10am!to!2pm.!This!event!is!hosted!by!the!University!of!Mississippi!School!of!Pharmacy!and!Funderburk’s!Pharmacy.!For!the!first!90!people,!18!years!and!older,!we!are!providing!FREE!flu!shots!!Also,!don’t!forget!to!bring!your!prescription!and!over!the!counter!medicine!bottles!with!you!for!a!free!medication!review.!Please!come!Saturday,!November!2,!at!Desoto!Health!and!Wellness!located!at!8889!Northwest!Dr.!in!Southaven.!Call!662Q393Q9848!for!more!information.!!
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APPENDIX D: PARTICIPATION SCRIPT 
 
 
 !Hello,!I’m!a!student!at!the!University!of!Mississippi.!Would!you!be!willing!to!take!a!brief!survey!regarding!the!medication!management!services!you!just!received?!!!If!“YES”:!Thank!you.!Are!you!at!least!18!years!old?!!If!“YES”:!Great,!please!complete!the!survey!and!place!it!in!the!collection!envelope.!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
